Observation units in the management of acute heart failure syndromes.

Current Heart Failure Reports
Gregory J Fermann, Sean P Collins

Abstract

Observation units (OUs) for acute heart failure syndromes (AHFS) have proven to be effective in reducing heart failure admissions and may reduce costs. Goals for risk-stratifying patients with AHFS in OUs include determining patients suitable for OU management and determining end points of treatment. Although many provider models and settings exist, management algorithms common to most OUs include monitoring/nursing care, diagnostic procedures, therapy, and educational/social services. The focus of OU management involves an assessment of the factors that led to the decompensation and identification of the predominant clinical features such as hypertension and congestion. Acute therapy still leans heavily on symptom relief with diuretics and nitroglycerin. For newly diagnosed patients, initiation of guideline-recommended therapies like angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers is an integral part of OU protocols. Patient education and coordination of outpatient care continues to be paramount in preventing early readmission in this patient population.

References

Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Mar 28, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
May 1, 2002·JAMA : the Journal of the American Medical Association·Anthony F Jerant
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Jonathan D Sackner-BernsteinKeith Aaronson
Sep 27, 2005·The Journal of Emergency Medicine·W F PeacockC L Emerman
Dec 21, 2005·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Charles V PollackJudd E Hollander
Jan 3, 2006·Annals of Emergency Medicine·W Frank PeacockCharles Emerman
Jun 9, 2006·Congestive Heart Failure·Marc A SilverDeborah B Diercks
Jan 4, 2007·JAMA : the Journal of the American Medical Association·Gregg C FonarowUNKNOWN OPTIMIZE-HF Investigators and Hospitals
Mar 22, 2007·The Annals of Pharmacotherapy·Vikrant VatsGlen T Schumock
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 25, 2008·American Heart Journal·Gregg C Fonarow
Mar 22, 2008·Emergency Medicine Journal : EMJ·W F PeacockC L Emerman
May 16, 2008·The New England Journal of Medicine·W Frank PeacockUNKNOWN ADHERE Investigators
Jun 28, 2008·Journal of the American College of Cardiology·Nirat BeoharMihai Gheorghiade
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Flávia M R VitalAlvaro N Atallah
Jul 24, 2008·JAMA : the Journal of the American Medical Association·Sanjiv J Shah, Mihai Gheorghiade
Nov 26, 2008·Heart Failure Clinics·Jon W Schrock, Charles L Emerman
Dec 17, 2008·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Dec 17, 2008·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Franklin A Michota, Alpesh Amin
Jan 17, 2009·Journal of the American College of Cardiology·James D FlahertyUNKNOWN Acute Heart Failure Syndromes International Working Group
Feb 14, 2009·Journal of the American College of Cardiology·Mihai Gheorghiade, Peter S Pang
Mar 31, 2009·The American Journal of Emergency Medicine·Sean P CollinsMark H Eckman
Jun 9, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Brian P LucasJulia L Bienias
Oct 6, 2009·Annals of Emergency Medicine·Dickson S CheungUNKNOWN Section of Quality Improvement and Patient Safety, American College of Emergency Physicians
Jan 19, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Julie B McCauslandDonald M Yealy
Sep 3, 2010·Journal of the Neurological Sciences·Nadzeya Kuzniatsova, Gregory Y H Lip

❮ Previous
Next ❯

Citations

Sep 24, 2013·The Journal of Emergency Medicine·Nancy M AlbertElizabeth Nykun
Jun 8, 2013·Journal of Cardiac Failure·Michael M GivertzRandall C Starling
Jul 3, 2013·Heart Failure Clinics·Gregory J Fermann, Sean P Collins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.